Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-market Clinical Investigation of the Angio-Seal™ VIP VCD: A Prospective, Multi-center Observational Study (ANGIO-SEAL CLOSE)

NCT05335525 is registered in ClinicalTrials.gov with Terumo Europe N.V. as lead sponsor.

NCT NCT05335525
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05335525 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-market Clinical Investigation of the Angio-Seal™ VIP VCD: A Prospective, Multi-center Observational Study (ANGIO-SEAL CLOSE)
Lead sponsor
Terumo Europe N.V.
Phase
Observational
Overall status
Unknown status
Start date
September 30, 2022
Completion date
May 31, 2023
Enrollment
230 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

endovascular procedure, femoral artery, hemostasis, peripheral vascular disease, vascular closure